Literature DB >> 7838392

Alteration of inositol 1,4,5-trisphosphate receptor after six-hour hemispheric ischemia in the gerbil brain.

E Nagata1, K Tanaka, S Gomi, B Mihara, T Shirai, S Nogawa, H Nozaki, K Mikoshiba, Y Fukuuchi.   

Abstract

In order to evaluate the influence of cerebral ischemia on the inositol 1,4,5-trisphosphate receptor, the alterations of inositol 1,4,5-trisphosphate receptor binding sites and local cerebral blood flow were examined 6 h after occlusion of the right common carotid artery in the gerbil brain. The autoradiographic method developed in our laboratory enabled us to measure both parameters within the same brain. Animals attaining ischemic scores of more than 5, as assessed 1 h after occlusion, were utilized. The local cerebral blood flow was measured 6 h after occlusion by the [14C]iodoantipyrine method. The inositol 1,4,5-trisphosphate binding sites were evaluated in vitro using [3H]inositol 1,4,5-trisphosphate as a specific ligand. The local cerebral blood flow fell below 15 ml/100 g per min in most of the cerebral regions on the occluded side. In contrast, a significant reduction in inositol 1,4,5-trisphosphate binding sites was noted only in the hippocampus CA1 on the occluded side. Inositol 1,4,5-trisphosphate binding tended to decrease when the values of local cerebral blood flow were below 20 ml/100 g per min in this region. On the other hand, the inositol 1,4,5-trisphosphate receptor immunoreactivity in the brain examined with a monoclonal antibody against inositol 1,4,5-trisphosphate receptor protein did not reveal any differences between the ischemia and sham groups on both sides, suggesting that the inositol 1,4,5-trisphosphate receptors may not undergo significant morphological degradation. These findings indicate that the suppression of inositol 1,4,5-trisphosphate binding in the hippocampus CA1 may be attributable to a regionally specific perturbation of the inositol 1,4,5-trisphosphate metabolism in this region.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838392     DOI: 10.1016/0306-4522(94)90418-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

Review 1.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

2.  Alteration of ryanodine receptor in the hippocampus CA1 after hemispheric cerebral ischemia.

Authors:  H Nozaki; K Tanaka; S Gomi; B Mihara; S Nogawa; E Nagata; T Kondo; Y Fukuuchi
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

3.  Ischemia-induced inhibition of active calcium transport into gerbil brain microsomes: effect of anesthetics and models of ischemia.

Authors:  P Racay; P Kaplán; J Lehotský
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

Review 4.  Role of the ryanodine receptor in ischemic brain damage--localized reduction of ryanodine receptor binding during ischemia in hippocampus CA1.

Authors:  H Nozaki; K Tanaka; S Gomi; B Mihara; S Nogawa; E Nagata; T Kondo; Y Fukuuchi
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

5.  Calcium-activated calpain-2 is a mediator of beta cell dysfunction and apoptosis in type 2 diabetes.

Authors:  Chang-jiang Huang; Tatyana Gurlo; Leena Haataja; Safia Costes; Marie Daval; Sergey Ryazantsev; Xiuji Wu; Alexandra E Butler; Peter C Butler
Journal:  J Biol Chem       Date:  2009-10-27       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.